How can pharma better engage with male patients and encourage them to become more proactive when it comes to looking after their own health?

With a focus on open channels of communication, pharma and the NHS have the potential not just to survive, but to truly thrive.

Achieving equal and accurate representation in clinical trials has long been a challenge for the pharmaceutical industry. We have made great progress towards the goal of patient inclusivity, but what more can be done to ensure that all patient groups are adequately represented and how can digital help to achieve this?

Mace Rothenberg, Chief Medical Officer, Pfizer, speaks to us about his sustained passion for advancing the field of oncology, the importance of diverse representation in patient groups, and the challenges of balancing lifespan with health span.

How ‘recession-proof’ is pharma, and what challenges has COVID-19 posed to this famously robust industry?

How can the pharmaceutical industry and, in particular, medical affairs teams, take pragmatic approaches to combat and curb antimicrobial resistance?

Celebrity endorsements can transform a mediocre pharma campaign into a pitch-perfect hit, but choosing the right spokesperson is crucial. We explore the practice of attaching famous faces to campaigns and how to ensure a representative strikes the right chord

Labelling is the vessel through which vital instructions and information about products are communicated to end-users, and in the pharmaceutical industry, medical affairs are entrusted with safeguarding these products from misuse, by balancing scientific accuracy with conciseness and coherence.